Sensus Healthcare Reports Third Quarter 2022 Financial Results
Profitability continues with revenues up 64% to $9.0 million, diluted EPS of $0.11 compares with $0.01 a year ago Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 03, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company...
Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022
BOCA RATON, Fla., Oct. 27, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on...
Sensus Healthcare Introduces Silk™ Laser Hair Removal System
Only portable hair removal laser system with blended wavelengths for all skin phototypes to be launched at the Fall Clinical Dermatology ConferenceBOCA RATON, Fla, Oct. 20, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly...
Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference
BOCA RATON, Fla., Sept. 09, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that...
Sensus Healthcare Adds Dr. Mohammad K. Khan to Medical Advisory Board
Addition of World-Renowned Radiation Oncologist Deepens Pool of ExpertiseBOCA RATON, Fla., Sept. 07, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective...